Evaluating a new class of AKT/mTOR activators for HIV latency-reversing activity ex vivo and in vivo

Andrea Gramatica, Roland Schwarzer, William Brantley, Benjamin Varco-Merth, Hannah S. Sperber, Philip A. Hull, Mauricio Montano, Stephen A. Migueles, Danielle Rosenthal, Louise E. Hogan, Jeffrey R. Johnson, Thomas A. Packard, Zachary W. Grimmett, Eytan Herzig, Emilie Besnard, Michael Nekorchuk, Feng Hsiao, Steven G. Deeks, Michael Snape, Bernard KiernanNadia R. Roan, Jeffrey D. Lifson, Jacob D. Estes, Louis J. Picker, Eric Verdin, Nevan J. Krogan, Timothy J. Henrich, Mark Connors, Melanie Ott, Satish K. Pillai, Afam A. Okoye, Warner C. Greene

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Evaluating a new class of AKT/mTOR activators for HIV latency-reversing activity ex vivo and in vivo'. Together they form a unique fingerprint.

Medicine & Life Sciences

Agriculture & Biology